Please assess the completion status of the following clinical trial:

Trial Title: Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Moderate to severe abdominal pain due to chronic pancreatitis of at least 6 months duration.~Exclusion criteria:~* Mild pain on the Pain Intensity-Numeric Rating Scale \[PI-NRS\] at screening and randomization visits;~* Narcotic addiction;~* Recent pancreatic surgical or endoscopic intervention for chronic pancreatitis pain;~* Unwillingness to use study-defined rescue analgesia exclusively.~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- REGN475/SAR164877 (Type: EXPERIMENTAL): REGN475/SAR164877, single injection, dose depending on the participant's body weight
- Placebo (Type: PLACEBO_COMPARATOR): Placebo (for REGN475/SAR164877), single injection

Based on this trial design, predict the completion outcome and termination type (if applicable).